These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11929758)

  • 1. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors.
    Folsom AR; Cushman M; Tsai MY; Aleksic N; Heckbert SR; Boland LL; Tsai AW; Yanez ND; Rosamond WD
    Blood; 2002 Apr; 99(8):2720-5. PubMed ID: 11929758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis.
    Castaman G; Faioni EM; Tosetto A; Bernardi F
    Haematologica; 2003 Oct; 88(10):1182-9. PubMed ID: 14555316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.
    Simioni P; Tormene D; Prandoni P; Zerbinati P; Gavasso S; Cefalo P; Girolami A
    Blood; 2002 Mar; 99(6):1938-42. PubMed ID: 11877263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
    Marchiori A; Mosena L; Prins MH; Prandoni P
    Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers.
    Mingozzi F; Legnani C; Lunghi B; Scanavini D; Castoldi E; Palareti G; Marchetti G; Bernardi F
    Thromb Haemost; 2003 Jun; 89(6):983-9. PubMed ID: 12783110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort study.
    Tormene D; Fortuna S; Tognin G; Gavasso S; Pagnan A; Prandoni P; Simioni P
    J Thromb Haemost; 2005 Jul; 3(7):1414-20. PubMed ID: 15978097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Bulato C; Gavasso S; Rosing J; Castoldi E
    J Thromb Haemost; 2012 Jan; 10(1):73-80. PubMed ID: 22044617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism.
    Rodeghiero F; Tosetto A
    Ann Intern Med; 1999 Apr; 130(8):643-50. PubMed ID: 10215560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.
    Ridker PM; Hennekens CH; Selhub J; Miletich JP; Malinow MR; Stampfer MJ
    Circulation; 1997 Apr; 95(7):1777-82. PubMed ID: 9107163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of factor V deficiency with factor V HR2.
    Faioni EM; Castaman G; Asti D; Lussana F; Rodeghiero F
    Haematologica; 2004 Feb; 89(2):195-200. PubMed ID: 15003895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
    Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
    J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).
    Ohira T; Cushman M; Tsai MY; Zhang Y; Heckbert SR; Zakai NA; Rosamond WD; Folsom AR
    J Thromb Haemost; 2007 Jul; 5(7):1455-61. PubMed ID: 17425663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
    Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
    Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden).
    Faioni EM; Franchi F; Bucciarelli P; Margaglione M; De Stefano V; Castaman G; Finazzi G; Mannucci PM
    Blood; 1999 Nov; 94(9):3062-6. PubMed ID: 10556190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.